Enhanced bone morphogenic protein adenoviral gene delivery to bone marrow stromal cells using magnetic nanoparticle
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives: This study investigated the question of whether adenoviral magnetofection can be a suitable method for increasing the efficacy of gene delivery into bone marrow stromal cell (BMSC) and for generation of a high level of bone morphogenic protein (BMP) secretion at a minimized viral titer. Materials and Methods: Primary BMSCs were isolated from C57BL6 mice and transduced with adenoviral vectors encoding β galactosidase or BMP2 and BMP7. The level of BMP secretion, activity of osteoblast differentiation, and cell viability of magnetofection were measured and compared with those of the control group. Results: The expression level of β galactosidase showed that the cell transduction efficiency of AdLacZ increased according to the increased amount of magnetic nanoparticles. No change in cell viability was observed after magnetofection with 2 μL of magnetic nanoparticle. Secretion of BMP2 or BMP7 was accelerated after transduction of AdBMP2 and 7 with magnetofection. AdBMP2 adenoviral magnetofection resulted in up to 7.2-fold higher secretion of BMP2, compared with conventional AdBMP2-transduced BMSCs. Magnetofection also induced a dramatic increase in secretion of BMP7 by up to 10-fold compared to the control. Use of only 1 multiplicity of infection (moi) of magnetofection with adenoviral transduction of AdBMP2 or AdBMP7 resulted in significantly higher transgene expression compared to 20 moi of conventional adenoviral transduction. Conclusion: Magnetic particle-mediated gene transudation is a highly efficient method of gene delivery to BMSCs. Magnetofection can lower the amount of viral particles while improving the efficacy of gene delivery.
Abstract
Objectives: This study investigated the question of whether adenoviral magnetofection can be a suitable method for increasing the efficacy of gene delivery into bone marrow stromal cell (BMSC) and for generation of a high level of bone morphogenic protein (BMP) secretion at a minimized viral titer. Materials and Methods: Primary BMSCs were isolated from C57BL6 mice and transduced with adenoviral vectors encoding β galactosidase or BMP2 and BMP7. The level of BMP secretion, activity of osteoblast differentiation, and cell viability of magnetofection were measured and compared with those of the control group. Results: The expression level of β galactosidase showed that the cell transduction efficiency of AdLacZ increased according to the increased amount of magnetic nanoparticles. No change in cell viability was observed after magnetofection with 2 μL of magnetic nanoparticle. Secretion of BMP2 or BMP7 was accelerated after transduction of AdBMP2 and 7 with magnetofection. AdBMP2 adenoviral magnetofection resulted in up to 7.2-fold higher secretion of BMP2, compared with conventional AdBMP2-transduced BMSCs. Magnetofection also induced a dramatic increase in secretion of BMP7 by up to 10-fold compared to the control. Use of only 1 multiplicity of infection (moi) of magnetofection with adenoviral transduction of AdBMP2 or AdBMP7 resulted in significantly higher transgene expression compared to 20 moi of conventional adenoviral transduction. Conclusion: Magnetic particle-mediated gene transudation is a highly efficient method of gene delivery to BMSCs. Magnetofection can lower the amount of viral particles while improving the efficacy of gene delivery.
참고문헌 (31)
- Bianco P, "Bone marrow stromal stem cells: nature, biology, and potential applications", Stem Cells, 19, pp.180~192 (2001)
- Scherer F, "Krüger A, et al. Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo", Gene Ther, 9, pp.102~109 (2002)
- Plank C, "Magnetofection: enhancing and targeting gene delivery with superparamagnetic nanoparticles and magnetic fields", J Liposome Res, 13, pp.29~32 (2003)
- Edgell CJ, "Efficient gene transfer to human endothelial cells using DNA complexed to adenovirus particles", Biotechniques, 25, pp.264~272 (1998)
- Tanner FC, "Transfection of human endothelial cells", Cardiovasc Res, 35, pp.522~528 (1997)
- Krötz F, "Magnetofection--a highly efficient tool for antisense oligonucleotide delivery in vitro and in vivo", Mol Ther, 7, pp.700~710 (2003)
- Gazit D, "Engineered pluripotent mesenchymal cells integrate and differentiate in regenerating bone: a novel cell-mediated gene therapy", J Gene Med, 1, pp.121~133 (1999)
- Franceschi RT, "Gene therapy for bone formation: in vitro and in vivo osteogenic activity of an adenovirus expressing BMP7", J Cell Biochem, 78, pp.476~486 (2000)
- Gottschalk S, "A novel DNA-peptide complex for efficient gene transfer and expression in mammalian cells", Gene Ther, 3, pp.448~457 (1996)
- Haines AM, "CL22 - a novel cationic peptide for efficient transfection of mammalian cells", Gene Ther, 8, pp.99~110 (2001)
- Mehrara BJ, "Adenovirus-mediated gene therapy of osteoblasts in vitro and in vivo", J Bone Miner Res, 14, pp.1290~1301 (1999)
- Olmsted EA, "Adenovirus-mediated BMP2 expression in human bone marrow stromal cells", J Cell Biochem, 82, pp.11~21 (2001)
- Lieberman JR, "The effect of regional gene therapy with bone morphogenetic protein-2-producing bone-marrow cells on the repair of segmental femoral defects in rats", J Bone Joint Surg Am, 81, pp.905~917 (1999)
- Breitbart AS, "Gene-enhanced tissue engineering: applications for bone healing using cultured periosteal cells transduced retrovirally with the BMP-7 gene", Ann Plast Surg, 42, pp.488~495 (1999)
- Verma IM, "Gene therapy-promises, problems and prospects", Nature, 389, pp.239~242 (1997)
- Partridge K, "Adenoviral BMP-2 gene transfer in mesenchymal stem cells: in vitro and in vivo bone formation on biodegradable polymer scaffolds", Biochem Biophys Res Commun, 292, pp.144~152 (2002)
- Franceschi RT, "Gene therapy approaches for bone regeneration", Cells Tissues Organs, 176, pp.95~108 (2004)
- Russell WC, "Update on adenovirus and its vectors", J Gen Virol, 81, pp.2573~2604 (2000)
- Zhao M, "Combinatorial gene therapy for bone regeneration: cooperative interactions between adenovirus vectors expressing bone morphogenetic proteins 2, 4, and 7", J Cell Biochem, 95, pp.1~16 (2005)
- Raper SE, "Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer", Mol Genet Metab, 80, pp.148~158 (2003)
- Reid T, "Intravascular adenoviral agents in cancer patients: lessons from clinical trials", Cancer Gene Ther, 9, pp.979~986 (2002)
- Marshall E, "Gene therapy death prompts review of adenovirus vector", Science, 286, pp.2244~2245 (1999)
- Bergelson JM, "Receptors mediating adenovirus attachment and internalization", Biochem Pharmacol, 57, pp.975~979 (1999)
- Hung SC, "Lineage diffe-rentiation-associated loss of adenoviral susceptibility and Coxsackie-adenovirus receptor expression in human mesenchymal stem cells", Stem Cells, 22, pp.1321~1329 (2004)
- Sapet C, "High transfection efficiency of neural stem cells with magnetofection", Biotechniques, 50, pp.187~189 (2011)
- Sapet C, "Magnetic nanoparticles enhance adenovirus transduction in vitro and in vivo", Pharm Res, 29, pp.1203~1218 (2012)
- Veiseh O, "Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging", Adv Drug Deliv Rev, 62, pp.284~304 (2010)
- Plank C, "Magneto-fectionTM platform: from magnetic nanoparticles to novel nucleic acid therapeutics", Ther Deliv, 2, pp.717~726 (2011)
- Zhang Y, "Targeted delivery of human VEGF gene via complexes of magnetic nanoparticle-adenoviral vectors enhanced cardiac regeneration", PLoS One, 7, pp.e39490~ (2012)
- Takahashi K, "Induction of pluripotent stem cells from adult human fibroblasts by defined factors", Cell, 131, pp.861~872 (2007)
- Park HY, "Efficient generation of virus-free iPS cells using liposomal magnetofection", PLoS One, 7, pp.e45812~ (2012)